254 related articles for article (PubMed ID: 32139272)
1. Convolutional Neural Network Detection of Axillary Lymph Node Metastasis Using Standard Clinical Breast MRI.
Ren T; Cattell R; Duanmu H; Huang P; Li H; Vanguri R; Liu MZ; Jambawalikar S; Ha R; Wang F; Cohen J; Bernstein C; Bangiyev L; Duong TQ
Clin Breast Cancer; 2020 Jun; 20(3):e301-e308. PubMed ID: 32139272
[TBL] [Abstract][Full Text] [Related]
2. MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
Cattell RF; Kang JJ; Ren T; Huang PB; Muttreja A; Dacosta S; Li H; Baer L; Clouston S; Palermo R; Fisher P; Bernstein C; Cohen JA; Duong TQ
Clin Breast Cancer; 2020 Feb; 20(1):68-79.e1. PubMed ID: 31327729
[TBL] [Abstract][Full Text] [Related]
3. Discordant results in
Parisse-Di Martino S; Faure C; Mognetti T
Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
[TBL] [Abstract][Full Text] [Related]
4. Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy.
Ren T; Lin S; Huang P; Duong TQ
Clin Breast Cancer; 2022 Feb; 22(2):170-177. PubMed ID: 34384696
[TBL] [Abstract][Full Text] [Related]
5. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
6. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
7. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
8. Axillary Lymph Node Evaluation Utilizing Convolutional Neural Networks Using MRI Dataset.
Ha R; Chang P; Karcich J; Mutasa S; Fardanesh R; Wynn RT; Liu MZ; Jambawalikar S
J Digit Imaging; 2018 Dec; 31(6):851-856. PubMed ID: 29696472
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
13. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural network models to predict nodal status in clinically node-negative breast cancer.
Dihge L; Ohlsson M; Edén P; Bendahl PO; Rydén L
BMC Cancer; 2019 Jun; 19(1):610. PubMed ID: 31226956
[TBL] [Abstract][Full Text] [Related]
15. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer.
Rahbar H; Partridge SC; Javid SH; Lehman CD
Curr Probl Diagn Radiol; 2012; 41(5):149-58. PubMed ID: 22818835
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning.
Zhou LQ; Wu XL; Huang SY; Wu GG; Ye HR; Wei Q; Bao LY; Deng YB; Li XR; Cui XW; Dietrich CF
Radiology; 2020 Jan; 294(1):19-28. PubMed ID: 31746687
[TBL] [Abstract][Full Text] [Related]
17. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
18. Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art.
Calabrese A; Santucci D; Landi R; Beomonte Zobel B; Faiella E; de Felice C
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1587-1597. PubMed ID: 33758997
[TBL] [Abstract][Full Text] [Related]
19. Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT.
Futamura M; Asano T; Kobayashi K; Morimitsu K; Nawa M; Kanematsu M; Morikawa A; Mori R; Yoshida K
World J Surg Oncol; 2015 Feb; 13():49. PubMed ID: 25885028
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
